Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Part of the Deep Freeze brand family (generic: Pentane + Levomenthol)
MHRA licensed products
View all licensed products for Pentane + Levomenthol on the MHRA register
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 26 studies.
Reviews & meta-analyses: 1 · 2016–2023
Showing all 26 studies, sorted by most relevant.
J. Bugler, B. Marks, O. Mathieu, et al.
Combustion and Flame, 2016
Junichiro Kanazawa, M. Uchiyama
Synlett, 2018
Nicholas D. Measom, Kenneth Down, D. Hirst, et al.
ACS medicinal chemistry letters, 2017
I. S. Makarov, Cara E. Brocklehurst, K. Karaghiosoff, et al.
Angewandte Chemie, 2017
M. Elkelawy, H. Bastawissi, E. Shenawy, et al.
2021
Biodiesel extracted from Scenedesmus obliquus algae through transesterification was used in the current study. Due to the disadvantages of using pure biodiesel in engines, it was used as B50 (a blend of 50% diesel and 50% biodiesel). To enhance engine performance, n-pentane was used in different extents of 5, 10, and 15 ml per liter as an enhancer additive. Through performance tests, it was found that 15 ml of n-pentane per liter was the best addition as it caused an increase in the brake thermal efficiency of 7.1% and a decrease in brake specific fuel consumption of 6.4% compared to the elegant B50. Whereas for exhaust gases, there was an increase in nitrogen oxides, which was associated with the significant increase in exhaust temperature and the high oxygen content present in B50. In comparison, hydrocarbons emission decreased by 7.2% compared to B50 in contrast to carbon dioxide which increased by 22.3% over B50. The carbon monoxide and oxygen concentrations of the exhaust gases also decreased by 17.35% and 9.5%, respectively compared to B50. The results obtained indicated that there are a significant improvements in pressure evolution and heat release data, which depend on the role of the mixed fuel addition of n-pentane.
Abstract licence: CC BY-NC-ND
Xiaoshen Ma, D. Sloman, Yongxin Han, et al.
Organic letters, 2019
M. Sarafraz, Zhe Tian, I. Tlili, et al.
Journal of Thermal Analysis and Calorimetry, 2019
X. Hou, Yuan Qiu, Xiangwen Zhang, et al.
Chemical Engineering Journal, 2017
Xiaoshen Ma, Luu Nhat Pham
Asian Journal of Organic Chemistry, 2019
Anne Rodriguez, O. Herbinet, Zhandong Wang, et al.
2017
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.